BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/13/2023 12:15:07 PM | Browse: 217 | Download: 459
 |
Received |
|
2023-04-14 14:04 |
|
Peer-Review Started |
|
2023-04-14 14:04 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-06-13 01:49 |
|
Revised |
|
2023-06-18 22:18 |
|
Second Decision |
|
2023-07-04 02:43 |
|
Accepted by Journal Editor-in-Chief |
|
2023-07-04 10:05 |
|
Accepted by Executive Editor-in-Chief |
|
2023-07-13 23:22 |
|
Articles in Press |
|
2023-07-13 23:22 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-08-07 01:50 |
|
Publish the Manuscript Online |
|
2023-09-13 12:15 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
MicroRNA-155 mediates endogenous angiotensin II type 1 receptor regulation: implications for innovative type 2 diabetes mellitus management
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Konstantinos I Papadopoulos, Alexandra Papadopoulou and Tar-Choon Aw |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Konstantinos I Papadopoulos, MD, PhD, Chief Physician, Director, Director, Department of R&D, THAI StemLife, 566/3 THAI StemLife bldg., Soi Ramkhamhaeng 39 (Thepleela 1), Prachaouthit Rd., Wangthonglang, Bangkok 10310, Thailand. kostas@thaistemlife.co.th |
| Key Words |
Angiotensin II; Angiotensin II type 1 receptor; Arginase 2; L-type calcium channel; Mineralocorticoid receptor; MiRNA-155; Renin-angiotensin aldosterone system; Type 1/2 diabetes mellitus; Verapamil |
| Core Tip |
MicroRNAs (miRNA) are small, non-coding, one-stranded RNA molecules that can target and silence over 60% of human genes thereby effectively regulating huge genetic networks. MiRNAs are abundantly found in every human cell and their production is tightly controlled. They play critical roles in regulating almost every cellular pathway, numerous human diseases, and have been linked to the development of diabetes mellitus (DM) and the regulation of blood pressure. In this minireview, we comment on crucial miR-155 effects in type 2 DM (T2DM). Deeper mechanistical understanding of this miRNA’s permeating action may lead to innovative therapeutic approaches in T2DM. |
| Publish Date |
2023-09-13 12:15 |
| Citation |
Papadopoulos KI, Papadopoulou A, Aw TC. MicroRNA-155 mediates endogenous angiotensin II type 1 receptor regulation: implications for innovative type 2 diabetes mellitus management. World J Diabetes 2023; 14(9): 1334-1340 |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i9/1334.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i9.1334 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
